5th BSMA Europe
La Hulpe (Brussels), Belgium
NOVEMBER 12, 2020
BSMA AWARDS PROMOTION INFORMATION
Members of the BSMA Advisory Board have provided a variety of insights about their companies’ experiences during the COVID-19 crisis.
Clearly, supply chain has been one of the most impacted functions at all these life science firms. But BSMA leaders have demonstrated a willingness and ability to respond quickly and effectively. For example, many biopharmaceutical firms tap other groups for scenario planning and forecasting. MIT is one such group that
Devendra Mishra, Co-Founder and Executive Director, BSMA Life Sciences will never be the same as we have known it to be because the COVID-19 pandemic has claimed a hundred thousand human lives and over a million infected while devastating the economy in the US alone. A reality is creeping
Matt Yedwabnick, Senior Director, Supply Chain, Atara BiotherapeuticsBSMA leadership on COVID-19 supply chain challengesApril 7 2020 Atara Biotherapeutics is a clinical stage company developing off-the-shelf, allogeneic T-cell immunotherapy.“From our standpoint,” explained Matt Yedwabnick, Senior Director, Supply Chain at Atara, “many of the steps we have taken regarding managing supply chain
Illumina Operations Team Powers On During Pandemic to Support Human Health Kevin Pegels, Vice President, Global Supply Chain, Illumina According to Kevin Pegels, Vice President, Global Supply Chain, Illumina, during the COVID-19 pandemic, “Employee safety remains our #1 priority. Due to our role in making, testing, and shipping products used
ANDREW CUOMO, THE CHIEF SUPPLY CHAIN OFFICER OF THE WAR ON COVID-19 PANDEMIC – ANATOMY OF THE EVOLVING SUPPLY CHAIN OF HEALTHCARE!
From the Desk of Devendra Mishra Executive Director & Co-Founder, BSMA The most apocalyptic crisis since the global influenza pandemic of 1918-1919 has led to over a million people infected and 70,000 lives lost to COVID-19 a century later. In the absence of a timely national response, the most severely
by Robbie Singh, MS, MBA The current economic devastation of USA and Europe caused by the Coronavirus pandemic has produced a vision of how the Life Sciences industry could be shaped for the synergistic benefit to the two economies in the world. In order to develop a future state, let
Supply Chain Leader, Vice President, Global Supply Chain, Biopharmaceutical Company, April 8 2020 [Names prefer to remain anonymous] This leading Bay Area Biopharmaceutical Company has plugged into several benchmarking initiatives focused on COVID-19. One of these is sponsored by MIT’s Center for Transportation, and features regular calls. The Center provides
Stefano Volonte, Head, Supply Chain, North America, Genentech Stefano Volonte leads North America and LatAm commercial supply chain for Roche/Genentech. During the COVID-19 pandemic, he commented on three areas: Supply chain resilience By design, Roche/Genentech had already established dual/multiple locations for several, key products manufacturing, opting not to rely
Carla Reed, President & CEO, New Creed LLC The recent outbreak of the COVID-19 (Coronavirus) and the related supply chain interruptions has highlighted the vulnerability of global supply chains. Initial concern related to shutdowns in China production but as this country worked through the issues and restarted their production
Devendra Mishra, Co-Founder and Executive Director, BSMA History has taught us that it is in the DNA of America to emerge from a crisis better than before. This time of the Coronavirus pandemic, it is shaping up to be no different. Today the healthcare industry in America has been